Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2003-03-29
2009-06-09
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S217060, C514S227800, C514S256000, C540S481000, C540S601000, C544S060000, C544S326000
Reexamination Certificate
active
07544675
ABSTRACT:
The present invention concerns chemical compounds combining affinity and antagonism against the human m3 muscarinic receptor with activity as selective phosphodiesterase IV (PDE IV) inhibitors, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
REFERENCES:
patent: 3624084 (1971-11-01), Mathieu
patent: 0 256 670 (1988-02-01), None
patent: 0 300 726 (1989-01-01), None
Barnes, Frontrunners in novel pharmacotherapy of COPD, Current Opinion in Pharmacology 2008, 8:300-307.
Cazzola et al., Treating systemic effects of COPD, Trends in Pharmacological Sciences, vol. 28, No. 10, pp. 544-550, 2007.
Fox et al., Models of chronic obstructive pulmonary disease: a review of current status, Drug Discovery Today: Disease Models, vol. 1, No. 3, pp. 319-328 (2004).
Christophe Bernard
Provins Laurent
Surtees John
Talaga Patrice
Van Keulen Berend Jan
McDonnell Boehnen & Hulbert & Berghoff LLP
Rao Deepak
UCB S.A.
LandOfFree
Chemical compounds with dual activity, processes for their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chemical compounds with dual activity, processes for their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemical compounds with dual activity, processes for their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4114430